NCT02913482: Investigate Safety, Tolerability, PK, PD and Efficacy of Risdiplam (RO7034067) in Infants With Type1 Spinal Muscular Atrophy
- State
- Completed
- Phase
- Phase 2
- People
- 62 taking part
- Started
- 23 Dec 2016
- Primary completion
- 14 Nov 2019
- Arms
- Part 1 (Dose Finding): Risdiplam (RO7034067), Part 2 (Confirmatory): Risdiplam (RO7034067)
- Results
- Posted on the registry
- 23 Sep 2016: Trial registered
- 23 Dec 2016: Trial started
- 8 Jan 2021: Trial results posted
- 22 Dec 2023: Trial completed